FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983209361> ?p ?o ?g. }

• W1983209361 abstract "Abstract Background After the introduction of novel effective immunosuppressive therapies, kidney transplantation became the treatment of choice for end stage renal disease. While these new therapies lead to better graft survival, they can also cause a variety of complications. Only small series or case reports describe pulmonary pathology in renal allograft recipients on mTOR inhibitor inclusive therapies. The goal of this study was to provide a systematic review of thoracic biopsies in kidney transplant recipients for possible association between a type of immunosuppressive regimen and pulmonary complications. Methods A laboratory database search revealed 28 of 2140 renal allograft recipients (18 males and 10 females, 25 to 77 years old, mean age 53 years) who required a biopsy for respiratory symptoms. The histological features were correlated with clinical findings including immunosuppressive medications. Results The incidence of neoplasia on lung biopsy was 0.4% (9 cases), which included 3 squamous cell carcinomas, 2 adenocarcinomas, 1 diffuse large B-cell lymphoma, 1 lymphomatoid granulomatosis, and 2 post transplant B-cell lymphoproliferative disorders. Diffuse parenchymal lung disease was identified in 0.4% (9 cases), and included 5 cases of pulmonary hemorrhage, 3 cases of organizing pneumonia and 1 case of pulmonary alveolar proteinosis. Five (0.2%) cases showed histological features indicative of a localized infectious process. Patients on sirolimus had neoplasia less frequently than patients on other immunosuppressive combinations (12.5% vs. 58.3%, p = 0.03). Lung biopsies in 4 of 5 patients with clinically suspected sirolimus toxicity revealed pulmonary hemorrhage as the sole histological finding or in combination with other patterns. Conclusions Our study documents a spectrum of neoplastic and non-neoplastic lesions in renal allograft recipients on current immunosuppressive therapies. Sirolimus inclusive regimens are associated with increased risk of pulmonary toxicity but may be beneficial in cases of posttransplant neoplasia. Virtual Slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/3320012126569395 ." @default.
• W1983209361 created "2016-06-24" @default.
• W1983209361 creator A5028123428 @default.
• W1983209361 creator A5030315854 @default.
• W1983209361 creator A5033500089 @default.
• W1983209361 creator A5044705669 @default.
• W1983209361 creator A5051548428 @default.
• W1983209361 creator A5055139308 @default.
• W1983209361 creator A5068548841 @default.
• W1983209361 creator A5068800992 @default.
• W1983209361 creator A5076586861 @default.
• W1983209361 creator A5077634371 @default.
• W1983209361 date "2012-03-14" @default.
• W1983209361 modified "2023-09-25" @default.
• W1983209361 title "Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens" @default.
• W1983209361 cites W1965116575 @default.
• W1983209361 cites W1967320388 @default.
• W1983209361 cites W1977132432 @default.
• W1983209361 cites W1979666220 @default.
• W1983209361 cites W1980270575 @default.
• W1983209361 cites W1986026265 @default.
• W1983209361 cites W1986819764 @default.
• W1983209361 cites W1995976732 @default.
• W1983209361 cites W1999723203 @default.
• W1983209361 cites W2006630082 @default.
• W1983209361 cites W2008200942 @default.
• W1983209361 cites W2008291854 @default.
• W1983209361 cites W2012945996 @default.
• W1983209361 cites W2026351725 @default.
• W1983209361 cites W2027430489 @default.
• W1983209361 cites W2028301924 @default.
• W1983209361 cites W2036313386 @default.
• W1983209361 cites W2037926194 @default.
• W1983209361 cites W2048587601 @default.
• W1983209361 cites W2051763571 @default.
• W1983209361 cites W2052036695 @default.
• W1983209361 cites W2055890021 @default.
• W1983209361 cites W2056730178 @default.
• W1983209361 cites W2059333451 @default.
• W1983209361 cites W2060826753 @default.
• W1983209361 cites W2065541109 @default.
• W1983209361 cites W2068050449 @default.
• W1983209361 cites W2090793309 @default.
• W1983209361 cites W2093607033 @default.
• W1983209361 cites W2095482125 @default.
• W1983209361 cites W2113546389 @default.
• W1983209361 cites W2117368376 @default.
• W1983209361 cites W2137557270 @default.
• W1983209361 cites W2142862239 @default.
• W1983209361 cites W2146662658 @default.
• W1983209361 cites W2148724358 @default.
• W1983209361 cites W2149218373 @default.
• W1983209361 cites W2157898630 @default.
• W1983209361 cites W2159424016 @default.
• W1983209361 cites W2167383172 @default.
• W1983209361 cites W2322266288 @default.
• W1983209361 cites W2764507256 @default.
• W1983209361 cites W4235655819 @default.
• W1983209361 doi "https://doi.org/10.1186/1746-1596-7-25" @default.
• W1983209361 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3344684" @default.
• W1983209361 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22416975" @default.
• W1983209361 hasPublicationYear "2012" @default.
• W1983209361 type Work @default.
• W1983209361 sameAs 1983209361 @default.
• W1983209361 citedByCount "21" @default.
• W1983209361 countsByYear W19832093612012 @default.
• W1983209361 countsByYear W19832093612013 @default.
• W1983209361 countsByYear W19832093612014 @default.
• W1983209361 countsByYear W19832093612015 @default.
• W1983209361 countsByYear W19832093612016 @default.
• W1983209361 countsByYear W19832093612017 @default.
• W1983209361 countsByYear W19832093612018 @default.
• W1983209361 countsByYear W19832093612019 @default.
• W1983209361 countsByYear W19832093612020 @default.
• W1983209361 countsByYear W19832093612021 @default.
• W1983209361 countsByYear W19832093612022 @default.
• W1983209361 crossrefType "journal-article" @default.
• W1983209361 hasAuthorship W1983209361A5028123428 @default.
• W1983209361 hasAuthorship W1983209361A5030315854 @default.
• W1983209361 hasAuthorship W1983209361A5033500089 @default.
• W1983209361 hasAuthorship W1983209361A5044705669 @default.
• W1983209361 hasAuthorship W1983209361A5051548428 @default.
• W1983209361 hasAuthorship W1983209361A5055139308 @default.
• W1983209361 hasAuthorship W1983209361A5068548841 @default.
• W1983209361 hasAuthorship W1983209361A5068800992 @default.
• W1983209361 hasAuthorship W1983209361A5076586861 @default.
• W1983209361 hasAuthorship W1983209361A5077634371 @default.
• W1983209361 hasBestOaLocation W19832093611 @default.
• W1983209361 hasConcept C126322002 @default.
• W1983209361 hasConcept C142724271 @default.
• W1983209361 hasConcept C2777714996 @default.
• W1983209361 hasConcept C2777921159 @default.
• W1983209361 hasConcept C2779563453 @default.
• W1983209361 hasConcept C2780252810 @default.
• W1983209361 hasConcept C2909675724 @default.
• W1983209361 hasConcept C2911091166 @default.
• W1983209361 hasConcept C71924100 @default.
• W1983209361 hasConcept C90924648 @default.
• W1983209361 hasConceptScore W1983209361C126322002 @default.
• W1983209361 hasConceptScore W1983209361C142724271 @default.

• next